1. BRAF and MEK inhibitors rechallenge as effective treatment for patients with metastatic melanoma. Issue 5 (October 2020) Authors: Cybulska-Stopa, Bożena; Rogala, Paweł; Czarnecka, Anna M.; Galus, Łukasz; Dziura, Robert; Rajczykowski, Marcin; Kubiatowski, Tomasz; Wiśniewska, Magdalena; Gęga-Czarnota, Adrianna; Teterycz, Paweł; Ziobro, Marek; Suwiński, Rafał; Mackiewicz, Jacek; Rutkowski, Piotr Journal: Melanoma research Issue: Volume 30:Issue 5(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. High baseline neutrophil-to-lymphocyte ratio predicts worse outcome in patients with metastatic BRAF-positive melanoma treated with BRAF and MEK inhibitors. Issue 5 (October 2018) Authors: Teterycz, Paweł; Jagodzińska-Mucha, Paulina; Cybulska-Stopa, Bożena; Mariuk-Jarema, Anna; Kozak, Katarzyna; Koseła-Paterczyk, Hanna; Czarnecka, Anna M.; Rajczykowski, Marcin; Dziura, Robert; Galus, Łukasz; Mackiewicz, Jacek; Świtaj, Tomasz; Klimczak, Anna; Falkowski, Slawomir; Suwiński, Rafał; Zi... Journal: Melanoma research Issue: Volume 28:Issue 5(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗